drugset / Trial / NCT04190862

E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

NCT04190862 ↗

Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to determine if endothelial cells derived from human umbilical vein are safe for use in conjunction with fistulotomy for the treatment of simple anal fistulas. Endothelial cells are a special kind of cell in the body that line the inside surface of blood vessels. The goal of the study is to evaluate the preliminary safety of human umbilical vein cells in anal fistula healing.

Timeline

Start
2020-01-22
Primary completion
2026-09-30
Completion
2032-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject E-CEL UVEC Cell therapy 3e+07 cells Other

Indications